Details for Patent: 7,132,570

Which drugs does patent 7,132,570 protect, and when does it expire?

Patent 7,132,570 protects NUVIGIL and is included in one NDA.

Protection for NUVIGIL has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifty-four patent family members in twenty-nine countries.

Summary for Patent: 7,132,570

Title:	Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil
Abstract:	The invention relates to a process for the preparation of crystalline forms of the optical enantiomers of modafinil, comprising stages comprising: i) dissolving one of the optical enantiomers of modafinil in a solvent other than ethanol, ii) crystallising the modafinil enantiomer, iii) recovering the crystalline form of the modafinil enantiomer so obtained. The invention also relates to a process for the preparation of the optical enantiomers of modafinil.
Inventor(s):	Neckebrock; Olivier (Ponteau Combault, FR), Leproust; Pierre (Creteil, FR)
Assignee:	Cephalon France (Maisons-Alfort Cedex, FR)
Application Number:	10/539,918
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,132,570
Patent Claim Types: see list of patent claims	Composition; Process;

Drugs Protected by US Patent 7,132,570

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Cephalon	NUVIGIL	armodafinil	TABLET;ORAL	021875-001	Jun 15, 2007	AB	RX	Yes	No
Cephalon	NUVIGIL	armodafinil	TABLET;ORAL	021875-002	Mar 26, 2009		DISCN	Yes	No
Cephalon	NUVIGIL	armodafinil	TABLET;ORAL	021875-003	Jun 15, 2007	AB	RX	Yes	No
Cephalon	NUVIGIL	armodafinil	TABLET;ORAL	021875-005	Mar 26, 2009	AB	RX	Yes	No
Cephalon	NUVIGIL	armodafinil	TABLET;ORAL	021875-004	Jun 15, 2007	AB	RX	Yes	Yes

Foreign Priority and PCT Information for Patent: 7,132,570

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
France	02 16412	Dec 20, 2002

PCT Information
PCT Filed	December 18, 2003	PCT Application Number:	PCT/FR03/03799
PCT Publication Date:	July 22, 2004	PCT Publication Number:	WO20/04/060858

International Family Members for US Patent 7,132,570

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	042546
Australia	2003299349
Australia	2010212462
Brazil	0316916
Canada	2510096
Canada	2724305
Chile	2007002450